Ikarian Capital »

Genmab A/s -sp shares owned by Ikarian Capital

Quarter-by-quarter ownership of Genmab A/s -sp (GMAB) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Genmab A/s -sp

Tip: Access up to 7 years of quarterly data

All positions including Genmab A/s -sp held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genmab A/s -sp by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $53M 175k 302.98

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Genmab A/s -sp

Orbis Allan Gray
Alliancebernstein
Paradigm Biocapital Advisors
Arrowstreet Capital, Limited Partnership
Harding Loevner
BlackRock
Renaissance Technologies
Morgan Stanley
First Trust Advisors
Two Sigma Advisers
Brandywine Global Investment Management
Two Sigma Investments
FMR
Goldman Sachs Group
Northern Trust

View all funds holding Genmab A/s -sp